Motilal Oswal Flags 9–11% Pharma Growth in India by FY 26; Recommends Five Stocks

Motilal Oswal Wealth Management projects India’s pharmaceutical sector to grow at 9–11% by fiscal 2026 and has spotlighted five pharma and healthcare stocks—Lupin, Mankind Pharma, Piramal Pharma, IPCA Labs, and…

Indian pharma stocks tumble as Trump signals tariffs on drug imports

Indian pharmaceutical stocks slumped on Wednesday after US President Donald Trump renewed his threat to impose sweeping tariffs on all pharmaceutical imports, an announcement that sent shockwaves through drug industry…